Works matching IS 14620324 AND DT 2022 AND VI 61 AND IP 3


Results: 65
    1
    2
    3
    4
    5
    6
    7
    8
    9
    10
    11
    12
    13
    14
    15
    16
    17
    18
    20
    21
    22

    Genetic epidemiological analysis of hypouricaemia from 4993 Japanese on non-functional variants of URAT1/SLC22A12 gene.

    Published in:
    Rheumatology, 2022, v. 61, n. 3, p. 1276, doi. 10.1093/rheumatology/keab545
    By:
    • Nakayama, Akiyoshi;
    • Kawamura, Yusuke;
    • Toyoda, Yu;
    • Shimizu, Seiko;
    • Kawaguchi, Makoto;
    • Aoki, Yuka;
    • Takeuchi, Kenji;
    • Okada, Rieko;
    • Kubo, Yoko;
    • Imakiire, Toshihiko;
    • Iwasawa, Satoko;
    • Nakashima, Hiroshi;
    • Tsunoda, Masashi;
    • Ito, Keiichi;
    • Kumagai, Hiroo;
    • Takada, Tappei;
    • Ichida, Kimiyoshi;
    • Shinomiya, Nariyoshi;
    • Matsuo, Hirotaka
    Publication type:
    Article
    23
    24

    Anti-nuclear matrix protein 2 antibody-positive inflammatory myopathies represent extensive myositis without dermatomyositis-specific rash.

    Published in:
    Rheumatology, 2022, v. 61, n. 3, p. 1222, doi. 10.1093/rheumatology/keab518
    By:
    • Ichimura, Yuki;
    • Konishi, Risa;
    • Shobo, Miwako;
    • Inoue, Sae;
    • Okune, Mari;
    • Maeda, Akemi;
    • Tanaka, Ryota;
    • Kubota, Noriko;
    • Matsumoto, Isao;
    • Ishii, Akiko;
    • Tamaoka, Akira;
    • Shimbo, Asami;
    • Mori, Masaaki;
    • Morio, Tomohiro;
    • Kishi, Takayuki;
    • Miyamae, Takako;
    • Tanboon, Jantima;
    • Inoue, Michio;
    • Nishino, Ichizo;
    • Fujimoto, Manabu
    Publication type:
    Article
    25
    26
    27

    Digital pitting scars are associated with a severe disease course and death in systemic sclerosis: a study from the EUSTAR cohort.

    Published in:
    Rheumatology, 2022, v. 61, n. 3, p. 1141, doi. 10.1093/rheumatology/keab510
    By:
    • Hughes, Michael;
    • Heal, Calvin;
    • Henes, Jörg;
    • Balbir-Gurman, Alexandra;
    • Distler, Jörg H W;
    • Airò, Paolo;
    • Müller-Ladner, Ulf;
    • Hunzelmann, Nicolas;
    • Kerzberg, Eduardo;
    • Rudnicka, Lidia;
    • Truchetet, Marie-Elise;
    • Stebbings, Simon;
    • Tanaka, Yoshiya;
    • Hoffman-Vold, Anna Maria;
    • Gabrielli, Armando;
    • Distler, Oliver;
    • Matucci-Cerinic, Marco;
    • Collaborators, the EUSTAR
    Publication type:
    Article
    28
    29

    Inorganic pyrophosphate is reduced in patients with systemic sclerosis.

    Published in:
    Rheumatology, 2022, v. 61, n. 3, p. 1158, doi. 10.1093/rheumatology/keab508
    By:
    • Hsu, Vivien M;
    • Kozák, Eszter;
    • Li, Qiaoli;
    • Bocskai, Márta;
    • Schlesinger, Naomi;
    • Rosenthal, Ann;
    • McClure, Scott T;
    • Kovács, László;
    • Bálint, László;
    • Szamosi, Szilvia;
    • Szücs, Gabriella;
    • Carns, Mary;
    • Aren, Kathleen;
    • Goldberg, Isaac;
    • Váradi, András;
    • Varga, John
    Publication type:
    Article
    30
    31
    32
    33
    34

    Behçet's disease and activities of daily living.

    Published in:
    Rheumatology, 2022, v. 61, n. 3, p. 1133, doi. 10.1093/rheumatology/keab499
    By:
    • Nagano, Aoi;
    • Takeuchi, Masaki;
    • Horita, Nobuyuki;
    • Teshigawara, Takeshi;
    • Kawagoe, Tatsukata;
    • Mizuki, Yuki;
    • Meguro, Akira;
    • Nakano, Hiroto;
    • Kirino, Yohei;
    • Takase-Minegishi, Kaoru;
    • Yoshimi, Ryusuke;
    • Kurosawa, Michiko;
    • Fukumoto, Takeshi;
    • Takeno, Mitsuhiro;
    • Kaneko, Takeshi;
    • Mizuki, Nobuhisa
    Publication type:
    Article
    35
    36
    37
    38

    Autoantibody profiles delineate distinct subsets of scleromyositis.

    Published in:
    Rheumatology, 2022, v. 61, n. 3, p. 1148, doi. 10.1093/rheumatology/keab492
    By:
    • Leclair, Valérie;
    • D'Aoust, Julie;
    • Gyger, Geneviève;
    • Landon-Cardinal, Océane;
    • Meyer, Alain;
    • O'Ferrall, Erin;
    • Karamchandani, Jason;
    • Massie, Rami;
    • Ellezam, Benjamin;
    • Satoh, Minoru;
    • Troyanov, Yves;
    • Fritzler, Marvin J;
    • Hudson, Marie;
    • Group, the Canadian Inflammatory Myopathy Study
    Publication type:
    Article
    39
    40
    41
    42
    43
    44
    45

    Effect of the phosphodiesterase 4 inhibitor apremilast on cardiometabolic outcomes in psoriatic disease—results of the Immune Metabolic Associations in Psoriatic Arthritis study.

    Published in:
    Rheumatology, 2022, v. 61, n. 3, p. 1026, doi. 10.1093/rheumatology/keab474
    By:
    • Ferguson, Lyn D;
    • Cathcart, Susanne;
    • Rimmer, Dominic;
    • Semple, Gary;
    • Brooksbank, Katriona;
    • Paterson, Caron;
    • Brown, Rosemary;
    • Harvie, John;
    • Gao, Xuan;
    • Radjenovic, Aleksandra;
    • Welsh, Paul;
    • McInnes, Iain B;
    • Sattar, Naveed;
    • Siebert, Stefan
    Publication type:
    Article
    46
    47
    48
    49
    50